id	sid	eid	entity	type
ihlr-21701	1	1	microsoft	ORG
ihlr-21701	2	1	14	CARDINAL
ihlr-21701	2	2	1	CARDINAL
ihlr-21701	3	1	1	CARDINAL
ihlr-21701	4	1	2	CARDINAL
ihlr-21701	4	2	3	CARDINAL
ihlr-21701	5	1	samaritan	GPE
ihlr-21701	5	2	4	CARDINAL
ihlr-21701	5	3	u.s.	GPE
ihlr-21701	5	4	2002	DATE
ihlr-21701	5	5	supra supra access	PERSON
ihlr-21701	5	6	three	CARDINAL
ihlr-21701	5	7	the united states	GPE
ihlr-21701	5	8	the united states	GPE
ihlr-21701	6	1	years 2000	DATE
ihlr-21701	6	2	2007	DATE
ihlr-21701	6	3	d.	NORP
ihlr-21701	6	4	supra supra supra supra https://doi.org/10.1016/j.jmpt.2012.12.001 http://doi.org/10.1056/nejmra025411 https://doi.org/10.1213/01.ane.0000068822.10113.9e	PERSON
ihlr-21701	6	5	supra supra supra	PERSON
ihlr-21701	6	6	the 21st century	DATE
ihlr-21701	6	7	the past 40 years	DATE
ihlr-21701	6	8	https://doi.org/10.1016/j.pmn.2007.11.002	NORP
ihlr-21701	6	9	2014	DATE
ihlr-21701	7	1	d.	NORP
ihlr-21701	10	1	the united states	GPE
ihlr-21701	10	2	united states	GPE
ihlr-21701	10	3	1999-2008	DATE
ihlr-21701	10	4	the united states	GPE
ihlr-21701	10	5	2000-2010	DATE
ihlr-21701	10	6	u.s.	GPE
ihlr-21701	10	7	2001-2010	DATE
ihlr-21701	11	1	third	ORDINAL
ihlr-21701	12	1	the united states	GPE
ihlr-21701	12	2	the american academy of neurology supra	ORG
ihlr-21701	12	3	the united states	GPE
ihlr-21701	12	4	united states	GPE
ihlr-21701	12	5	2000	DATE
ihlr-21701	12	6	2014	DATE
ihlr-21701	12	7	north carolina	GPE
ihlr-21701	12	8	united states	GPE
ihlr-21701	12	9	2000–2014	CARDINAL
ihlr-21701	12	10	a decade	DATE
ihlr-21701	12	11	https://doi.org/10.1097/01.j.pain.0000460357.01998.f1 https://doi.org/10.1111/j.1526-4637.2011.01075.x https://doi.org/10.1001/jama.2011.370	WORK_OF_ART
ihlr-21701	13	1	$600 million	MONEY
ihlr-21701	14	1	5	CARDINAL
ihlr-21701	14	2	https://doi.org/10.1146/annurev-publhealth-031914-122957 https://doi.org/10.2105/ajph.2007.131714 https://doi.org/10.1016/j.drugalcdep.2016.04.002	ORG
ihlr-21701	14	3	the united states	GPE
ihlr-21701	14	4	d.	NORP
ihlr-21701	14	5	2006–2012	CARDINAL
ihlr-21701	14	6	the united states	GPE
ihlr-21701	14	7	2004-2013	DATE
ihlr-21701	14	8	https://doi.org/10.1093/cid/ciu643	GPE
ihlr-21701	15	1	https://doi.org/10.1097/01.eem.0000351378.22473.93	NORP
ihlr-21701	16	1	https://doi.org/10.1097/01.eem.0000342736.85273.cb	ORG
ihlr-21701	17	1	d.	NORP
ihlr-21701	17	2	supra supra supra	PERSON
ihlr-21701	17	3	baltimore	GPE
ihlr-21701	17	4	maryland	GPE
ihlr-21701	17	5	1995-2009	DATE
ihlr-21701	17	6	https://doi.org/10.1111/j.1360-0443.2011.03676.x	DATE
ihlr-21701	18	1	the united states	GPE
ihlr-21701	18	2	https://doi.org/10.1097/adm.0b013e3181d41ddb https://doi.org/10.1016/s0376-8716(03)00055-3	ORG
ihlr-21701	18	3	the american medical association	ORG
ihlr-21701	18	4	fda	ORG
ihlr-21701	18	5	supra supra	PERSON
ihlr-21701	18	6	d. supra supra	PERSON
ihlr-21701	19	1	supra supra supra supra	PERSON
ihlr-21701	19	2	supra supra supra prescriptions	PERSON
ihlr-21701	20	1	d.	NORP
ihlr-21701	20	2	d.	NORP
ihlr-21701	20	3	d.	NORP
ihlr-21701	20	4	d.	NORP
ihlr-21701	21	1	d.	NORP
ihlr-21701	22	1	d.	NORP
ihlr-21701	23	1	d.	NORP
ihlr-21701	24	1	d.	NORP
ihlr-21701	25	1	d.	NORP
ihlr-21701	26	1	d.	NORP
ihlr-21701	27	1	d.	NORP
ihlr-21701	28	1	d.	NORP
ihlr-21701	29	1	d.	NORP
ihlr-21701	30	1	d.	NORP
ihlr-21701	31	1	d.	NORP
ihlr-21701	32	1	d.	NORP
ihlr-21701	35	1	d.	NORP
ihlr-21701	36	1	d.	NORP
ihlr-21701	37	1	d.	NORP
ihlr-21701	39	1	d.	NORP
ihlr-21701	39	2	d.	NORP
ihlr-21701	40	1	d.	NORP
ihlr-21701	42	1	d.	NORP
ihlr-21701	43	1	d.	NORP
ihlr-21701	46	1	d.	NORP
ihlr-21701	47	1	d.	NORP
ihlr-21701	48	1	d.	NORP
ihlr-21701	49	1	d.	NORP
ihlr-21701	50	1	d.	NORP
ihlr-21701	51	1	d.	NORP
ihlr-21701	53	1	https://doi.org/10.1377/hlthaff.2016.0098 a. access	PERSON
ihlr-21701	54	1	united states	GPE
ihlr-21701	54	2	2000-2014	DATE
ihlr-21701	55	1	italian	NORP
ihlr-21701	55	2	two	CARDINAL
ihlr-21701	55	3	new york city	GPE
ihlr-21701	55	4	united states	GPE
ihlr-21701	55	5	2010	DATE
ihlr-21701	55	6	https://doi.org/10.1177/2042098614564776 https://doi.org/10.2147/oaem.s82133	PERSON
ihlr-21701	55	7	united states	GPE
ihlr-21701	55	8	2014	DATE
ihlr-21701	55	9	d.	NORP
ihlr-21701	55	10	cdc	ORG
ihlr-21701	55	11	united states	GPE
ihlr-21701	55	12	2016	CARDINAL
ihlr-21701	55	13	massachusetts	GPE
ihlr-21701	57	1	rhode island	GPE
ihlr-21701	57	2	the united states	GPE
ihlr-21701	57	3	https://doi.org/10.7326/0003-4819-158-1-201301010-00003 https://doi.org/10.1186/1471-2458-14-297 https://doi.org/10.1007/s11524-006-9120-z	LOC
ihlr-21701	57	4	1	CARDINAL
ihlr-21701	58	1	the united states	GPE
ihlr-21701	58	2	2	CARDINAL
ihlr-21701	59	1	d.	NORP
ihlr-21701	60	1	d.	NORP
ihlr-21701	61	1	d.	NORP
ihlr-21701	62	1	samaritan	GPE
ihlr-21701	62	2	2004	DATE
ihlr-21701	63	1	d. luke colossians	PERSON
ihlr-21701	65	1	d.	NORP
ihlr-21701	68	1	samaritan	GPE
ihlr-21701	68	2	4	CARDINAL
ihlr-21701	68	3	chesterfield	GPE
ihlr-21701	68	4	upton	PERSON
ihlr-21701	69	1	d.	NORP
ihlr-21701	69	2	d.	NORP
ihlr-21701	69	3	d.	NORP
ihlr-21701	69	4	d.	NORP
ihlr-21701	70	1	australia	GPE
ihlr-21701	70	2	reschedules naloxone	PERSON
ihlr-21701	70	3	canada	GPE
ihlr-21701	70	4	fda	ORG
ihlr-21701	74	1	d.	NORP
ihlr-21701	75	1	d.	NORP
ihlr-21701	76	1	fda	ORG
ihlr-21701	76	2	america	GPE
ihlr-21701	76	3	https://doi.org/10.1056/nejmra011080	PRODUCT
ihlr-21701	76	4	united states	GPE
ihlr-21701	76	5	20002014	DATE
ihlr-21701	76	6	united states	GPE
ihlr-21701	76	7	2000-2013	DATE
ihlr-21701	76	8	united states	GPE
ihlr-21701	76	9	2000-2014	DATE
ihlr-21701	76	10	the united states	GPE
ihlr-21701	76	11	texas	GPE
ihlr-21701	76	12	united states	GPE
ihlr-21701	76	13	2002-2014	DATE
ihlr-21701	76	14	https://doi.org/10.1016/j.drugalcdep.2016.04.002	GPE